Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC)

Conditions:   COVID;   COVID-19;   SARS-CoV-2;   SARS (Severe Acute Respiratory Syndrome) Interventions:   Drug: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG);   Other: Placebo;   Drug: Remdesivir Sponsors:   University of Minnesota;   National Institute of Allergy and Infectious Diseases (NIAID);   National Institutes of Health (NIH);   The International Network for Strategic Initiatives in Global HIV Trials Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials